U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863974) titled 'High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Dissemi... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864091) titled 'Different Manufacturing Techniques of Facial Prostheses' on Feb. 27. Brief Summary: All pa... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863480) titled 'Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events' on March 03. Brief... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863376) titled 'Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty ... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864273) titled 'Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter He... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864260) titled 'Cancer Prevention Through Enhanced EnvironMent' on March 03. Brief Summary: The goal of Ca... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864429) titled 'Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle ... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865131) titled 'Efficacy Study with StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breas... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863831) titled 'A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Che... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864182) titled 'Relative Bioavailability Study of CX2101A for the Treatment of COVID-19' on Feb. 24. Brief... Read More